Heyman Tomas J. 4
4 · Akero Therapeutics, Inc. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Heyman Tomas J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-08+26,000→ 26,000 totalExercise: $23.02Exp: 2034-06-07→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the earlier of (i) June 7, 2025, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board.